Prosecution Insights
Last updated: August 17, 2026
Application No. 18/441,798

PULSATILE ASPIRATION SYSTEM USING A STATIC VACUUM SOURCE WITH INTERMITTENT INJECTION OF A PRESSURE PULSE

Non-Final OA §112
Filed
Feb 14, 2024
Priority
Feb 22, 2023 — provisional 63/447,506
Examiner
PONTON, JAMES D
Art Unit
Tech Center
Assignee
NEURAVI Limited
OA Round
1 (Non-Final)
80%
Grant Probability
Favorable
1-2
OA Rounds
4m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 80% — above average
80%
Career Allowance Rate
455 granted / 566 resolved
+20.4% vs TC avg
Strong +32% interview lift
Without
With
+32.5%
Interview Lift
resolved cases with interview
Typical timeline
2y 10m
Avg Prosecution
37 currently pending
Career history
591
Total Applications
across all art units

Statute-Specific Performance

§101
1.3%
-38.7% vs TC avg
§103
40.9%
+0.9% vs TC avg
§102
16.0%
-24.0% vs TC avg
§112
37.2%
-2.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 566 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Administrative MPEP 608.01(i) includes the requirements of 37 CFR 1.75, with part (i) stating, “Where a claim sets forth a plurality of elements or steps, each element or step of the claim should be separated by a line indentation.” While the term “should” does not absolutely require the claims to follow this format it does help in establishing the metes and bounds of the claim by clearly indicating which structural elements are required. The examiner suggests amending Claim 11 to follow 37 CFR 1.75(i) for providing clarification on the intended interpretation of the claimed inventions. Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. Claims 1-20 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. As to claim 1, usage of “therethrough” in line 4 is unclear as it is not apparent what component “therethrough” refers to (e.g. the opposite distal end, the outer wall, the catheter, etc…). As to claim 1, usage of “thereof” in line 6 is unclear as it is not apparent what component “thereof” refers to (e.g. the proximal section, the proximal section of the passageway, etc…). As to claim 1, usage of “therethrough” in line 8 is unclear as it is not apparent what component “therethrough” refers to (e.g. the distal section, the passageway, the catheter, etc…). Claim 1 recites the limitation "the distal end of the catheter" in three instances. While the claim did previously refer to a distal end of an outer wall, a distal end of an outer wall is not necessarily always synonymous with a distal of a catheter, and therefore it is not apparent whether “the distal end of the catheter” is intended to be read as the part as the distal end of the outer wall or if “the distal end of the catheter” is intended to refer to a different part. The examiner notes that claims 6 and 8 also refer to “the distal end of the catheter”. Claims 2-10 are rejected as they depend from a rejected claim. As to claim 11, usage of “therethrough” in line 3 is unclear as it is not apparent what component “therethrough” refers to (e.g. the opposite distal end, the outer wall, the catheter, etc…). As to claim 11, usage of “thereof” in line 5 is unclear as it is not apparent what component “thereof” refers to (e.g. the proximal section, the proximal section of the passageway, etc…). As to claim 11, usage of “therethrough” in line 7 is unclear as it is not apparent what component “therethrough” refers to (e.g. the distal section, the passageway, the catheter, etc…). Claim 11 recites the limitation "the distal end of the catheter" in three instances. While the claim did previously refer to a distal end of an outer wall, a distal end of an outer wall is not necessarily always synonymous with a distal of a catheter, and therefore it is not apparent whether “the distal end of the catheter” is intended to be read as the same part as the distal end of the outer wall or if “the distal end of the catheter” is intended to refer to a different part. The examiner notes that claims 12 and 14 also refer to “the distal end of the catheter”. Claims 12-20 are rejected as they depend from a rejected claim. Allowable Subject Matter Claims 1-20 would be allowable if rewritten or amended to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action. As to claim 1, the closest prior art appears to be Grey et al. (WO 2014151209 A1, provided by applicant on 6/27/24 and hereafter “Grey”). Grey discloses a pulsatile aspiration system (see Figs. 2A-3C) comprising: a catheter (206) comprising: an outer wall extending in a longitudinal direction from a proximal end (end attached to 212a) to an opposite distal end (end near 202) defining a passageway therethrough (not numbered, however clear from at least pages 6-7 that a lumen extends through catheter 206); a proximal section with an associated proximal section of the passageway; a distal section disposed distally thereof with an associated distal section of the passageway (see Fig. 2A; both “sections” can be interpreted arbitrarily). Grey also teaches supplying a dynamic pressure waveform at a distal end of the catheter by using a pump system (208) (see page 9, Figs. 2C-3C discussing method steps and example waveforms, also see para beginning line 16 col. 11). However, Grey is silent to an internal wall extending in the longitudinal direction therethrough and dividing the proximal section of the passageway into (i) a central main lumen defined radially inward relative to the internal wall and (ii) an auxiliary lumen at least partially defined by the internal wall and internal to the outer wall, the central main lumen, through which a first fluid is receivable, being configured to produce one of negative fluid pressure or positive fluid pressure therein, the auxiliary lumen, through which a second fluid is receivable, being configured to produce the other of the positive fluid pressure or the negative fluid pressure therein, and a distal portion of the central main lumen and a distal portion of the auxiliary lumen are in fluid communication with one another where the negative fluid pressure and the positive fluid pressure combine as a resulting pressure in the distal section of the passageway; and a pump system in fluid communication with the catheter and independently controlling the negative fluid pressure and the positive fluid pressure in the central main lumen and the auxiliary lumen so as to produce at the distal end of the catheter a pulsatile aspiration waveform variable between a maximum aspiration pressure and a maximum positive pressure, the maximum aspiration pressure being producible at the distal end of the catheter when the resulting pressure is exclusively negative fluid pressure, and the maximum positive pressure being producible at the distal end of the catheter when the positive fluid pressure counterbalances that of the negative fluid pressure. Yurek (US 2021/0121188 A1) discloses a catheter (102) comprising an internal wall extending in a longitudinal direction and dividing a proximal section of a passageway into (i) a central main lumen defined radially inward relative to the internal wall and (ii) an auxiliary lumen at least partially defined by the internal wall and internal to the outer wall, the central main lumen, through which a first fluid is receivable (see Fig. 1 and Figs. 5A-6A depicting various embodiments, also see para 0082-0085). However Yurik does not teach the pump system or the limitations above regarding a pulsatile aspiration waveform variable between a maximum aspiration pressure and a maximum positive pressure, the maximum aspiration pressure being producible at the distal end of the catheter when the resulting pressure is exclusively negative fluid pressure, and the maximum positive pressure being producible at the distal end of the catheter when the positive fluid pressure counterbalances that of the negative fluid pressure. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to James D Ponton whose telephone number is (571)272-1001. The examiner can normally be reached M-F 9am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Chelsea Stinson can be reached at 571-270-1744. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /James D Ponton/Primary Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Feb 14, 2024
Application Filed
Jul 16, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12702749
PAD FOR ADHERING A MEDICAMENT DELIVERY DEVICE TO THE SKIN, INCLUDING A NEEDLE
3y 11m to grant Granted Aug 11, 2026
Patent 12702750
Fluid Transfer System for Drug Delivery Device
3y 5m to grant Granted Aug 11, 2026
Patent 12697472
DRUG DELIVERY DEVICE INCLUDING PUMP WITH FLOATING MICRONEEDLE ASSEMBLY
4y 5m to grant Granted Aug 04, 2026
Patent 12697433
DISPLACEMENT PUMP MECHANISM WITH FRANGIBLE RESERVOIR, MEDICAMENT DELIVERY SYSTEM, PATCH PUMP AND MEDICAMENT DELIVERY DEVICE
3y 6m to grant Granted Aug 04, 2026
Patent 12697434
DEVICE FOR SUBCUTANEOUS DELIVERY OF FLUID MEDICAMENT
3y 7m to grant Granted Aug 04, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
80%
Grant Probability
99%
With Interview (+32.5%)
2y 10m (~4m remaining)
Median Time to Grant
Low
PTA Risk
Based on 566 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month